Patent 11771652 was granted and assigned to Sanofi on October, 2023 by the United States Patent and Trademark Office.
Provided are novel lipid nanoparticles for delivering nucleic acids such as mRNA. Also provided are methods of making and using lipid nanoparticles for delivering nucleic acids such as mRNA.